News Daily News Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass Yael L. Maxwell January 14, 2026
News Daily News FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement Michael O'Riordan December 23, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC Yael L. Maxwell October 27, 2025
News Daily News Money Talk: Cardiologists Must Weigh Costs as Transcatheter Therapies Ascend Caitlin E. Cox August 11, 2025
News Conference News NY Valves 2025 MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed Yael L. Maxwell July 03, 2025
News Conference News EuroPCR 2025 Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage Yael L. Maxwell May 21, 2025
News Conference News SCAI 2025 BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients L.A. McKeown May 07, 2025
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News EACTS 2024 AI-Based CT Can Accurately Screen Patients for TMVR Yael L. Maxwell October 15, 2024
Presentation EACTS 2024 Streamlining Transcatheter Mitral Valve Replacement Screening Presenter: Martin Beyer October 10, 2024
News Conference News HFSA 2024 EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER Caitlin E. Cox October 03, 2024
News Conference News NY Valves 2024 TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy Todd Neale June 11, 2024
News Daily News TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction Michael O'Riordan May 06, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Conference News STS 2024 SAVR After Failed TAVI on the Rise, With High Mortality Yael L. Maxwell February 05, 2024